EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.5.1.60 | 3,5-dichloro-4-nitropyridine | AM11095, synthetis of the specific brain permeable NAAA inhibitor, a slowly reversible NAAA inhibitor | Homo sapiens | |
3.5.1.60 | 3,5-dichloro-4-nitropyridine | AM11095, synthetis is of the specific brain permeable NAAA inhibitor, a slowly reversible NAAA inhibitor | Rattus norvegicus |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
3.5.1.60 | lysosome | - |
Homo sapiens | 5764 | - |
3.5.1.60 | lysosome | - |
Rattus norvegicus | 5764 | - |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.1.60 | N-oleoylethanolamide + H2O | Homo sapiens | - |
oleate + ethanolamine | - |
? | |
3.5.1.60 | N-oleoylethanolamide + H2O | Rattus norvegicus | - |
oleate + ethanolamine | - |
? | |
3.5.1.60 | N-oleoylethanolamide + H2O | Rattus norvegicus Sprague-Dawley | - |
oleate + ethanolamine | - |
? | |
3.5.1.60 | N-palmitoylethanolamide + H2O | Homo sapiens | - |
palmitate + ethanolamine | - |
? | |
3.5.1.60 | N-palmitoylethanolamide + H2O | Rattus norvegicus | - |
palmitate + ethanolamine | - |
? | |
3.5.1.60 | N-palmitoylethanolamide + H2O | Rattus norvegicus Sprague-Dawley | - |
palmitate + ethanolamine | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.5.1.60 | Homo sapiens | Q02083 | - |
- |
3.5.1.60 | Rattus norvegicus | Q6P7S1 | - |
- |
3.5.1.60 | Rattus norvegicus Sprague-Dawley | Q6P7S1 | - |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.5.1.60 | brain | - |
Homo sapiens | - |
3.5.1.60 | brain | - |
Rattus norvegicus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.5.1.60 | N-oleoylethanolamide + H2O | - |
Homo sapiens | oleate + ethanolamine | - |
? | |
3.5.1.60 | N-oleoylethanolamide + H2O | - |
Rattus norvegicus | oleate + ethanolamine | - |
? | |
3.5.1.60 | N-oleoylethanolamide + H2O | - |
Rattus norvegicus Sprague-Dawley | oleate + ethanolamine | - |
? | |
3.5.1.60 | N-palmitoylethanolamide + H2O | - |
Homo sapiens | palmitate + ethanolamine | - |
? | |
3.5.1.60 | N-palmitoylethanolamide + H2O | - |
Rattus norvegicus | palmitate + ethanolamine | - |
? | |
3.5.1.60 | N-palmitoylethanolamide + H2O | - |
Rattus norvegicus Sprague-Dawley | palmitate + ethanolamine | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.5.1.60 | N-acylethanolamine acid amidase | - |
Homo sapiens |
3.5.1.60 | N-acylethanolamine acid amidase | - |
Rattus norvegicus |
3.5.1.60 | NAAA | - |
Homo sapiens |
3.5.1.60 | NAAA | - |
Rattus norvegicus |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
3.5.1.60 | 0.00002 | - |
pH and temperature not specified in the publication | Homo sapiens | 3,5-dichloro-4-nitropyridine |
EC Number | General Information | Comment | Organism |
---|---|---|---|
3.5.1.60 | malfunction | effects of pretreatment with the NAAA inhibitor AM11095 on nicotine-related effects in the rat mesolimbic dopamine system, phenotype, detailed overview | Rattus norvegicus |